Form 4 for HRMY Harmony Biosciences Holdings, Inc.
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0000899243-21-042746 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-11-03 | 2021-11-01 | HRMY | Dierks Jeffrey | Chief Commercial Off | S - Sale+OE | $41.68 | -10.0K | 0 | -100% | -$416.8K |
| D | 2021-11-03 | 2021-11-01 | HRMY | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $8.22 | +10.0K | 10.0K | New | +$82.2K |
| DM | 2021-11-03 | 2021-11-01 | HRMY | Dierks Jeffrey | Chief Commercial Off | M - OptEx | $0.00 | -10.0K | 19.5K | -34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | S | D | 7,054 | $41.36 | 2,946 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.03 to $42.02. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-11-01 | S | D | 2,946 | $42.44 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.03 to $43.00. The reporting person undertakes to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-11-01 | M | A | 10,000 | $8.22 | 10,000 | D | — | — | |
| 4 | Derivative | Stock Option | 2021-11-01 | M | D | 6,048 | $0.00 | 13,429 | D | $8.22 · — to 2027-10-02 | 6,048 Common Stock | (F5) Reflects 785 additional stock options which were erroneously reported as exercised on the Form 4 filed by the reporting person on September 3, 2021, but which were actually exercised from the tranche which expires on October 1, 2028. (F4) The stock option is currently vested with respect to 3,690 shares, and will vest with respect to the remainder of the shares on October 1, 2022. |
| 5 | Derivative | Stock Option | 2021-11-01 | M | D | 3,952 | $0.00 | 19,476 | D | $8.22 · — to 2030-03-04 | 3,952 Common Stock | (F6) The stock option is currently vested with respect to 0 shares, and will vest with respect to the remainder of the shares in four equal annual installments beginning on March 1, 2022. |